290 related articles for article (PubMed ID: 18818676)
1. Clinical severity correlates with impaired barrier in filaggrin-related eczema.
Nemoto-Hasebe I; Akiyama M; Nomura T; Sandilands A; McLean WH; Shimizu H
J Invest Dermatol; 2009 Mar; 129(3):682-9. PubMed ID: 18818676
[TBL] [Abstract][Full Text] [Related]
2. Impact of filaggrin mutations on Raman spectra and biophysical properties of the stratum corneum in mild to moderate atopic dermatitis.
Mlitz V; Latreille J; Gardinier S; Jdid R; Drouault Y; Hufnagl P; Eckhart L; Guinot C; Tschachler E
J Eur Acad Dermatol Venereol; 2012 Aug; 26(8):983-90. PubMed ID: 21812836
[TBL] [Abstract][Full Text] [Related]
3. Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema.
Jungersted JM; Scheer H; Mempel M; Baurecht H; Cifuentes L; Høgh JK; Hellgren LI; Jemec GB; Agner T; Weidinger S
Allergy; 2010 Jul; 65(7):911-8. PubMed ID: 20132155
[TBL] [Abstract][Full Text] [Related]
4. Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency.
Kezic S; O'Regan GM; Lutter R; Jakasa I; Koster ES; Saunders S; Caspers P; Kemperman PM; Puppels GJ; Sandilands A; Chen H; Campbell LE; Kroboth K; Watson R; Fallon PG; McLean WH; Irvine AD
J Allergy Clin Immunol; 2012 Apr; 129(4):1031-9.e1. PubMed ID: 22322004
[TBL] [Abstract][Full Text] [Related]
5. A homozygous nonsense mutation in the gene for Tmem79, a component for the lamellar granule secretory system, produces spontaneous eczema in an experimental model of atopic dermatitis.
Sasaki T; Shiohama A; Kubo A; Kawasaki H; Ishida-Yamamoto A; Yamada T; Hachiya T; Shimizu A; Okano H; Kudoh J; Amagai M
J Allergy Clin Immunol; 2013 Nov; 132(5):1111-1120.e4. PubMed ID: 24060273
[TBL] [Abstract][Full Text] [Related]
6. Filaggrin loss-of-function mutations are not a predisposing factor for atopic dermatitis in an Ishigaki Island under subtropical climate.
Sasaki T; Furusyo N; Shiohama A; Takeuchi S; Nakahara T; Uchi H; Hirota T; Tamari M; Shimizu N; Ebihara T; Amagai M; Furue M; Hayashi J; Kudoh J
J Dermatol Sci; 2014 Oct; 76(1):10-5. PubMed ID: 25086748
[TBL] [Abstract][Full Text] [Related]
7. [Epidermal barrier function abnormalities in atopic dermatitis caused by filaggrin mutations].
Korge B
Hautarzt; 2009 Jun; 60(6):522. PubMed ID: 19444396
[No Abstract] [Full Text] [Related]
8. Concentration of filaggrin monomers, its metabolites and corneocyte surface texture in individuals with a history of atopic dermatitis and controls.
Engebretsen KA; Bandier J; Kezic S; Riethmüller C; Heegaard NHH; Carlsen BC; Linneberg A; Johansen JD; Thyssen JP
J Eur Acad Dermatol Venereol; 2018 May; 32(5):796-804. PubMed ID: 29360238
[TBL] [Abstract][Full Text] [Related]
9. Pyrrolidone carboxylic acid levels or caspase-14 expression in the corneocytes of lesional skin correlates with clinical severity, skin barrier function and lesional inflammation in atopic dermatitis.
Jung M; Choi J; Lee SA; Kim H; Hwang J; Choi EH
J Dermatol Sci; 2014 Dec; 76(3):231-9. PubMed ID: 25315296
[TBL] [Abstract][Full Text] [Related]
10. Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice.
Kawasaki H; Nagao K; Kubo A; Hata T; Shimizu A; Mizuno H; Yamada T; Amagai M
J Allergy Clin Immunol; 2012 Jun; 129(6):1538-46.e6. PubMed ID: 22409988
[TBL] [Abstract][Full Text] [Related]
11. Filaggrin loss-of-function mutations and levels of filaggrin degradation products in adult patients with atopic dermatitis in Croatia.
Jurakic Toncic R; Kezic S; Jakasa I; Ljubojevic Hadzavdic S; Balic A; Petkovic M; Pavicic B; Zuzul K; Marinovic B
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1789-1794. PubMed ID: 31989686
[TBL] [Abstract][Full Text] [Related]
12. Filaggrin mutations in relation to skin barrier and atopic dermatitis in early infancy.
Hoyer A; Rehbinder EM; Färdig M; Asad S; Lødrup Carlsen KC; Endre KMA; Granum B; Haugen G; Hedlin G; Monceyron Jonassen C; Katayama S; Konradsen JR; Landrø L; LeBlanc M; Olsson Mägi CA; Rudi K; Skjerven HO; Staff AC; Vettukattil R; Bradley M; Nordlund B; Söderhäll C
Br J Dermatol; 2022 Mar; 186(3):544-552. PubMed ID: 34698386
[TBL] [Abstract][Full Text] [Related]
13. Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age.
Flohr C; England K; Radulovic S; McLean WH; Campbel LE; Barker J; Perkin M; Lack G
Br J Dermatol; 2010 Dec; 163(6):1333-6. PubMed ID: 21137118
[TBL] [Abstract][Full Text] [Related]
14. Filaggrin breakdown products determine corneocyte conformation in patients with atopic dermatitis.
Riethmuller C; McAleer MA; Koppes SA; Abdayem R; Franz J; Haftek M; Campbell LE; MacCallum SF; McLean WHI; Irvine AD; Kezic S
J Allergy Clin Immunol; 2015 Dec; 136(6):1573-1580.e2. PubMed ID: 26071937
[TBL] [Abstract][Full Text] [Related]
15. Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity.
Kezic S; O'Regan GM; Yau N; Sandilands A; Chen H; Campbell LE; Kroboth K; Watson R; Rowland M; McLean WH; Irvine AD
Allergy; 2011 Jul; 66(7):934-40. PubMed ID: 21261659
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of Korean patients with filaggrin-related atopic dermatitis.
Park KY; Park MK; Seok J; Li K; Seo SJ
Clin Exp Dermatol; 2016 Aug; 41(6):595-600. PubMed ID: 27339295
[TBL] [Abstract][Full Text] [Related]
17. Epidermal tight junction barrier function is altered by skin inflammation, but not by filaggrin-deficient stratum corneum.
Yokouchi M; Kubo A; Kawasaki H; Yoshida K; Ishii K; Furuse M; Amagai M
J Dermatol Sci; 2015 Jan; 77(1):28-36. PubMed ID: 25511077
[TBL] [Abstract][Full Text] [Related]
18. Analysis of filaggrin mutations and expression in corneal specimens from patients with or without atopic dermatitis.
Lapp T; Auw-Haedrich C; Reinhard T; Evans R; Rodríguez E; Weidinger S; Jakob T
Int Arch Allergy Immunol; 2014; 163(1):20-4. PubMed ID: 24247645
[TBL] [Abstract][Full Text] [Related]
19. Possible new therapeutic strategy to regulate atopic dermatitis through upregulating filaggrin expression.
Otsuka A; Doi H; Egawa G; Maekawa A; Fujita T; Nakamizo S; Nakashima C; Nakajima S; Watanabe T; Miyachi Y; Narumiya S; Kabashima K
J Allergy Clin Immunol; 2014 Jan; 133(1):139-46.e1-10. PubMed ID: 24055295
[TBL] [Abstract][Full Text] [Related]
20. Moisturizing treatment of patients with atopic dermatitis and ichthyosis vulgaris improves dry skin, but has a modest effect on gene expression regardless of FLG genotype.
Hoppe T; Winge MC; Bradley M; Nordenskjöld M; Vahlquist A; Törmä H; Berne B
J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):174-7. PubMed ID: 24330146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
